Our organization is in the process of converting all outpatient and inpatient topiramate oral solutions over the the new commercially available product. We use Epic as our EMR and wondering what safety measures other organizations have used to make this a safe transition.

On the in-patient units we were compounding to 20 mg/mL to match ASHP Standardize-4-Safety, but our out-patient pharmacy within the same organization was compounding to 6 mg/mL as requested by a pediatric neurology clinic that writes most of our prescriptions.

Any help or advice is appreciated.